Jonathan Allan - 06 Dec 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Reporting relationship: GENERAL COUNSEL & CORP SEC
Issuer ticker: STOK
Reported as of: 06 Dec 2024
Net transaction value: -$123,891
SEC form: 4
Accepted by SEC: 10 Dec 2024, 19:01:47 UTC
Prior SEC filing: 05 Dec 2024
Next SEC filing: 11 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Allan

Key filing fact

Jonathan Allan filed Form 4 for Stoke Therapeutics, Inc. (STOK) on 10 Dec 2024.

Key facts

This page summarizes Jonathan Allan's Form 4 filing for Stoke Therapeutics, Inc. (STOK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Dec 2024, 19:01.

Change

Previous filing in this sequence was filed on 05 Dec 2024.
Current net transaction value: -$123,891.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STOK transaction

Common Stock

Sale

Transaction value: $123,891
Shares: -9,696
Change %: -22%
Price: $12.78
Shares after: 35,142
Date: 06 Dec 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.93 to $13.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.